ZA919438B - Use of xanthines for the preparation of a medicament having immuno supressing activity - Google Patents
Use of xanthines for the preparation of a medicament having immuno supressing activityInfo
- Publication number
- ZA919438B ZA919438B ZA919438A ZA919438A ZA919438B ZA 919438 B ZA919438 B ZA 919438B ZA 919438 A ZA919438 A ZA 919438A ZA 919438 A ZA919438 A ZA 919438A ZA 919438 B ZA919438 B ZA 919438B
- Authority
- ZA
- South Africa
- Prior art keywords
- supressing
- xanthines
- immuno
- medicament
- activity
- Prior art date
Links
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940065721 systemic for obstructive airway disease xanthines Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62048090A | 1990-11-30 | 1990-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA919438B true ZA919438B (en) | 1992-08-26 |
Family
ID=24486121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA919438A ZA919438B (en) | 1990-11-30 | 1991-11-29 | Use of xanthines for the preparation of a medicament having immuno supressing activity |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0490181A1 (enExample) |
| JP (1) | JPH06100450A (enExample) |
| KR (1) | KR920009399A (enExample) |
| CA (1) | CA2056723A1 (enExample) |
| HU (1) | HUT59825A (enExample) |
| IE (1) | IE914163A1 (enExample) |
| IL (1) | IL100195A0 (enExample) |
| PT (1) | PT99659A (enExample) |
| TW (1) | TW205507B (enExample) |
| ZA (1) | ZA919438B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992021344A2 (en) * | 1991-05-24 | 1992-12-10 | Fred Hutchinson Cancer Research Center | Modulation of cellular response to external stimuli |
| DE4411660A1 (de) * | 1994-04-05 | 1995-10-12 | Hoechst Ag | Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung |
| DE4430128A1 (de) * | 1994-08-25 | 1996-02-29 | Hoechst Ag | Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen |
| DE4430127A1 (de) * | 1994-08-25 | 1996-03-14 | Hoechst Ag | Kombinationspräparat, enthaltend Cyclosporin A oder FK506 und ein Xanthinderivat |
| US6323201B1 (en) | 1994-12-29 | 2001-11-27 | The Regents Of The University Of California | Compounds for inhibition of ceramide-mediated signal transduction |
| EP0956855B1 (en) * | 1998-04-24 | 2003-03-12 | K.U. Leuven Research & Development | Immunosuppressive effects of 8 substituted xanthine derivatives |
| US6930101B1 (en) | 1999-05-17 | 2005-08-16 | The Regents Of The University Of California | Thiazolopyrimidines useful as TNFα inhibitors |
| US7253176B1 (en) | 2000-05-04 | 2007-08-07 | K.U. Leuven Research & Development | Immunosuppressive effects of 8-substituted xanthine derivatives |
| KR20100121527A (ko) | 2008-02-29 | 2010-11-17 | 콘서트 파마슈티컬즈, 인크. | 치환된 잔틴 유도체 |
| US20110053961A1 (en) | 2009-02-27 | 2011-03-03 | Concert Pharmaceuticals, Inc. | Substituted xanthine derivatives |
| IN2012DN01642A (enExample) | 2009-09-02 | 2015-06-05 | Concert Pharmaceuticals Inc | |
| EP2611807A2 (en) | 2010-09-01 | 2013-07-10 | Concert Pharmaceuticals Inc. | Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione |
| US20140296263A1 (en) | 2011-07-19 | 2014-10-02 | Concert Pharmaceuticals, Inc. | Substituted xanthine derivatives |
| MX2014012384A (es) | 2012-04-13 | 2014-11-26 | Concert Pharmaceuticals Inc | Derivados sustituidos de xantina. |
| WO2013159006A1 (en) | 2012-04-20 | 2013-10-24 | Concert Pharmaceuticals, Inc. | Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione |
| US9549869B2 (en) | 2012-06-29 | 2017-01-24 | Hill-Rom Canado Respiratory Ltd. | Wearable thorax percussion device |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0063827B1 (fr) * | 1980-05-02 | 1985-08-14 | Societe Des Produits Nestle S.A. | 1-Isopropyl- et 1-isobutyl-3,7-diméthylxanthine comme médicaments |
| IL84934A (en) * | 1986-12-31 | 1994-08-26 | Hoechst Roussel Pharma | Pharmaceutical preparations containing xanthan history to stop the activity of interleukin-1 and leukocyte-derived cytokines |
| US4965271A (en) * | 1986-12-31 | 1990-10-23 | Hoechst Roussel Pharmaceuticals, Inc. | Method of inhibiting the activity of leukocyte derived cytokines |
| GB8918297D0 (en) * | 1989-08-10 | 1989-09-20 | Beecham Group Plc | Novel treatment |
-
1991
- 1991-11-28 EP EP91120425A patent/EP0490181A1/en not_active Withdrawn
- 1991-11-28 IL IL100195A patent/IL100195A0/xx unknown
- 1991-11-29 IE IE416391A patent/IE914163A1/en not_active Application Discontinuation
- 1991-11-29 JP JP3316210A patent/JPH06100450A/ja active Pending
- 1991-11-29 KR KR1019910021768A patent/KR920009399A/ko not_active Withdrawn
- 1991-11-29 PT PT99659A patent/PT99659A/pt not_active Application Discontinuation
- 1991-11-29 CA CA002056723A patent/CA2056723A1/en not_active Abandoned
- 1991-11-29 ZA ZA919438A patent/ZA919438B/xx unknown
- 1991-11-29 HU HU913721A patent/HUT59825A/hu unknown
-
1992
- 1992-03-06 TW TW081101708A patent/TW205507B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2056723A1 (en) | 1992-05-31 |
| PT99659A (pt) | 1992-10-30 |
| HUT59825A (en) | 1992-07-28 |
| IE914163A1 (en) | 1992-06-03 |
| HU913721D0 (en) | 1992-02-28 |
| IL100195A0 (en) | 1992-08-18 |
| TW205507B (enExample) | 1993-05-11 |
| EP0490181A1 (en) | 1992-06-17 |
| JPH06100450A (ja) | 1994-04-12 |
| KR920009399A (ko) | 1992-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9011588D0 (en) | Prostaglandin analogues for use in medicine | |
| GB9219999D0 (en) | Preparation of a medicament | |
| GR890100579A (en) | Consolidated sanitary napkin structure | |
| ZA911451B (en) | Clinical bed | |
| GB8828477D0 (en) | Medical aerosol formulations | |
| GB2255503B (en) | Improved use of ß2-bronchodilator drugs | |
| ZA919438B (en) | Use of xanthines for the preparation of a medicament having immuno supressing activity | |
| GB8911259D0 (en) | Inhalation medicament | |
| GB9000241D0 (en) | Pharmaceutical use | |
| EP0467537A3 (en) | Novel benzothiazepine esters, their preparation and formulations for therapeutic use | |
| GB9010038D0 (en) | Preparation of a medicament | |
| GB8802391D0 (en) | Medicinal formulations | |
| IE882467L (en) | Pharmaceutical preparation for external use | |
| GB9025377D0 (en) | Compounds having antiviral and cytotoxic activity | |
| GB9017548D0 (en) | Therapeutic preparation | |
| GB8816731D0 (en) | Tonometer | |
| GB9013657D0 (en) | Disposable napkin | |
| GB9022711D0 (en) | A novel use of a therapeutic agent | |
| HU905867D0 (en) | Medical preparation | |
| GB8829873D0 (en) | Preparation of an artefact | |
| GB9004831D0 (en) | Pharmaceutical preparation | |
| HU908149D0 (en) | Medical napkins | |
| GB9022669D0 (en) | Medicament | |
| GB9006432D0 (en) | Prostagladin analogues for use in medicine | |
| GB8901158D0 (en) | Administering drugs |